🇺🇸 FDA
Patent

US 9988602

Methods for producing enucleated erythroid cells derived from pluripotent stem cells

granted A61KA61K35/12A61P

Quick answer

US patent 9988602 (Methods for producing enucleated erythroid cells derived from pluripotent stem cells) held by Astellas Institute for Regenerative Medicine expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K35/12, A61P, A61P7/00, A61P7/06